Main > UROLOGY > Erectile Dysfunction > Treatment. > Tadalafil > Co.: USA. E (Brand Tablet/Patent)

---

Co.: USA. E (Brand Tablet/Patent)'s subsections
Company
Mechanism: PDE-5 Inhibition
Once/Day 2.5 & 5 mg Approved
Patent>Daily Dosing
Patent>DisClosure
Patent>Sexual DysFunction Treat.
Patent>Total USA No.: 3
Patent>UpDate: 01.08.08
Patent>USA Expiration: 11.21.2017
Status: Approved
Systematic (IUPAC) Name
TradeMark
UpDate: 01.08.08
Web-Site
Web-Site (Press Release)

Co.: USA. E (Brand Tablet/Patent)'s products
This section has no products